Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.8 ILa | -2.97% | +8.89% | +180.00% |
30/04 | XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
29/04 | Top Premarket Gainers | MT |
1st Jan change | Capi. | |
---|---|---|
+180.00% | 1.5Cr | |
+29.77% | 4.95TCr | |
+1.00% | 4.26TCr | |
+49.79% | 4.25TCr | |
-5.26% | 2.91TCr | |
+13.68% | 2.66TCr | |
-22.99% | 1.86TCr | |
+8.22% | 1.32TCr | |
+32.41% | 1.25TCr | |
+24.01% | 1.21TCr |
- Stock Market
- Equities
- XTLB Stock
- News XTL Biopharmaceuticals Ltd.
- XTL Biopharmaceuticals Ltd. Elects Alexander Rabinovitch as Directors